Tags

Type your tag names separated by a space and hit enter

Formal analysis of the optimal duration of tilt testing for the diagnosis of neurally mediated syncope.
Am Heart J. 2001 Feb; 141(2):282-8.AH

Abstract

BACKGROUND

Although tilt testing has emerged as the test of choice for assessing patients with suspected neurally mediated syncope, the optimum duration of tilt testing is poorly defined. This in part relates to the absence of a gold standard to assess test performance.

OBJECTIVE

Our purpose was to formally estimate the effects of varying duration of drug-free tilt testing on test performance in diagnosing neurally mediated syncope.

DESIGN

If a test's specificity is known, then in the absence of a gold standard an imputed (estimated) sensitivity may be calculated on the basis of the observed diagnostic yield in a given population as a function of assumed population prevalence. We determined the relationship of specificity to drug-free tilt test duration by use of data from 11 previous studies reporting the results of drug-free tilt testing in a total of 435 control subjects (60 to 80 degrees of tilt, footboard support, 15- to 60-minute duration). Data (weighted for study size) were fit to an exponential function relating specificity to tilt duration. Test yield was evaluated as a function of tilt duration in 213 consecutive patients referred to our laboratory for the evaluation of suspected neurally mediated syncope who underwent passive tilt testing for up to 30 to 60 minutes.

RESULTS

The estimated specificity of tilt testing was 94% at 30 minutes, 92% at 40 minutes, and 88% after 60 minutes of passive tilt. The cumulative yield of tilt testing was only 17% at 30 minutes, 22% at 40 minutes, and 28% after 60 minutes. On the basis of an estimated population prevalence of 25% to 50% in this referral population, imputed sensitivity is 27% to 48% at 30 minutes, 36% to 64% at 40 minutes, and 43% to 74% after 60 minutes of passive tilt. The overall diagnostic accuracy was not strongly influenced by tilt duration beyond 30 minutes and ranged from 60% to 84%.

CONCLUSIONS

Passive tilt testing (ie, tilt testing without pharmacologic provocation) for durations of up to 60 minutes has limited sensitivity for diagnosing neurally mediated syncope. For populations with a pretest likelihood of 25% to 50%, test results are inaccurate in one to two fifths of patients.

Authors+Show Affiliations

Division of Cardiology, Starr-4, Department of Medicine, New York Hospital-Cornell Medical Center, 525 E. 68th St., New York, NY 10021, USA. kstein@mail.med.cornell.eduNo affiliation info availableNo affiliation info availableNo affiliation info availableNo affiliation info availableNo affiliation info available

Pub Type(s)

Comparative Study
Journal Article
Research Support, U.S. Gov't, P.H.S.

Language

eng

PubMed ID

11174344

Citation

Stein, K M., et al. "Formal Analysis of the Optimal Duration of Tilt Testing for the Diagnosis of Neurally Mediated Syncope." American Heart Journal, vol. 141, no. 2, 2001, pp. 282-8.
Stein KM, Slotwiner DJ, Mittal S, et al. Formal analysis of the optimal duration of tilt testing for the diagnosis of neurally mediated syncope. Am Heart J. 2001;141(2):282-8.
Stein, K. M., Slotwiner, D. J., Mittal, S., Scheiner, M., Markowitz, S. M., & Lerman, B. B. (2001). Formal analysis of the optimal duration of tilt testing for the diagnosis of neurally mediated syncope. American Heart Journal, 141(2), 282-8.
Stein KM, et al. Formal Analysis of the Optimal Duration of Tilt Testing for the Diagnosis of Neurally Mediated Syncope. Am Heart J. 2001;141(2):282-8. PubMed PMID: 11174344.
* Article titles in AMA citation format should be in sentence-case
TY - JOUR T1 - Formal analysis of the optimal duration of tilt testing for the diagnosis of neurally mediated syncope. AU - Stein,K M, AU - Slotwiner,D J, AU - Mittal,S, AU - Scheiner,M, AU - Markowitz,S M, AU - Lerman,B B, PY - 2001/2/15/pubmed PY - 2001/4/3/medline PY - 2001/2/15/entrez SP - 282 EP - 8 JF - American heart journal JO - Am Heart J VL - 141 IS - 2 N2 - BACKGROUND: Although tilt testing has emerged as the test of choice for assessing patients with suspected neurally mediated syncope, the optimum duration of tilt testing is poorly defined. This in part relates to the absence of a gold standard to assess test performance. OBJECTIVE: Our purpose was to formally estimate the effects of varying duration of drug-free tilt testing on test performance in diagnosing neurally mediated syncope. DESIGN: If a test's specificity is known, then in the absence of a gold standard an imputed (estimated) sensitivity may be calculated on the basis of the observed diagnostic yield in a given population as a function of assumed population prevalence. We determined the relationship of specificity to drug-free tilt test duration by use of data from 11 previous studies reporting the results of drug-free tilt testing in a total of 435 control subjects (60 to 80 degrees of tilt, footboard support, 15- to 60-minute duration). Data (weighted for study size) were fit to an exponential function relating specificity to tilt duration. Test yield was evaluated as a function of tilt duration in 213 consecutive patients referred to our laboratory for the evaluation of suspected neurally mediated syncope who underwent passive tilt testing for up to 30 to 60 minutes. RESULTS: The estimated specificity of tilt testing was 94% at 30 minutes, 92% at 40 minutes, and 88% after 60 minutes of passive tilt. The cumulative yield of tilt testing was only 17% at 30 minutes, 22% at 40 minutes, and 28% after 60 minutes. On the basis of an estimated population prevalence of 25% to 50% in this referral population, imputed sensitivity is 27% to 48% at 30 minutes, 36% to 64% at 40 minutes, and 43% to 74% after 60 minutes of passive tilt. The overall diagnostic accuracy was not strongly influenced by tilt duration beyond 30 minutes and ranged from 60% to 84%. CONCLUSIONS: Passive tilt testing (ie, tilt testing without pharmacologic provocation) for durations of up to 60 minutes has limited sensitivity for diagnosing neurally mediated syncope. For populations with a pretest likelihood of 25% to 50%, test results are inaccurate in one to two fifths of patients. SN - 0002-8703 UR - https://www.unboundmedicine.com/medline/citation/11174344/Formal_analysis_of_the_optimal_duration_of_tilt_testing_for_the_diagnosis_of_neurally_mediated_syncope_ DB - PRIME DP - Unbound Medicine ER -